The Influence of Anti-Infective Periodontal Treatment on C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Demmer, Ryan T ^a   Trinquart, Ludovic ^b,c,d,e   Zuk, Aleksandra ^a   Fu, Benjamin C ^a   Blomkvist, Josefin ^b,c,d,e   Michalowicz, Bryan S ^f   Ravaud, Philippe ^a,b,c,d,e,g   Desvarieux, Moïse ^a,c,g  

^a Department of Medicine   (United States)

^b HÔTEL DIEU   (France)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e French Cochrane Centre   (France)

^f UNIVERSITY OF MINNESOTA   (United States)

^g EHESP SCHOOL OF PUBLIC HEALTH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ARTICLE; DRUG EFFICACY; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PERIODONTAL DISEASE; PREVENTIVE DENTISTRY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; THERAPY EFFECT;

ANTI-INFECTIVE AGENTS; C-REACTIVE PROTEIN; HUMANS; INFLAMMATION; PERIODONTITIS; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84885400384     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077441     Document Type: Article

References (68)

1. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM, (1993) Dental disease and risk of coronary heart disease and mortality. BMJ 306: 688-691. doi:10.1136/bmj.306.6879.688. PubMed: 8471920.
2. Wu T, Trevisan M, Genco RJ, Dorn JP, Falkner KL, et al. (2000) Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. Arch Intern Med 160: 2749-2755. doi:10.1001/archinte.160.18.2749. PubMed: 11025784.
3. Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR Jr., et al. (2005) Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111: 576-582. doi:10.1161/01.CIR.0000154582.37101.15. PubMed: 15699278.
4. Demmer RT, Desvarieux M, (2006) Periodontal infections and cardiovascular disease: The heart of the matter. J Am Dent Assoc 137 (Suppl):: 14S-20S. PubMed: 17012731.
5. Desvarieux M, Demmer RT, Jacobs DR Jr., Rundek T, Boden-Albala B, et al. (2010) Periodontal bacteria and hypertension: the oral infections and vascular disease epidemiology study (INVEST). J Hypertens 28: 1413-1421. doi:10.1097/HJH.0b013e328338cd36. PubMed: 20453665.
6. Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, (1998) Glycemic control and alveolar bone loss progression in type 2 diabetes. Ann Periodontol 3: 30-39. doi:10.1902/annals.1998.3.1.30. PubMed: 9722688.
7. Taylor GW, (2001) Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol 6: 99-112. doi:10.1902/annals.2001.6.1.99. PubMed: 11887478.
8. Janket SJ, Baird AE, Chuang SK, Jones JA, (2003) Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 559-569. doi:10.1067/moe.2003.107. PubMed: 12738947.
9. Mealey BL, (2006) Periodontal disease and diabetes. A two-way street. J Am Dent Assoc 137 (Suppl):: 26S-31S. PubMed: 17012733.
10. Saito T, Shimazaki Y, Kiyohara Y, Kato I, Kubo M, et al. (2004) The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: the Hisayama study. J Dent Res 83: 485-490. doi:10.1177/154405910408300610. PubMed: 15153457.
11. Demmer RT, Jacobs DR Jr., Desvarieux M, (2008) Periodontal disease and incident type 2 diabetes: results from the First National Health and Nutrition Examination Survey and its epidemiologic follow-up study. Diabetes Care 31: 1373-1379. doi:10.2337/dc08-0026. PubMed: 18390797.
12. Demmer RT, Desvarieux M, Holtfreter B, Jacobs DR Jr., Wallaschofski H, et al. (2010) Periodontal status and A1C change: longitudinal results from the study of health in Pomerania (SHIP). Diabetes Care 33: 1037-1043. doi:10.2337/dc09-1778. PubMed: 20185742.
13. Choi YH, McKeown RE, Mayer-Davis EJ, Liese AD, Song KB, et al. (2011) Association between periodontitis and impaired fasting glucose and diabetes. Diabetes Care 34: 381-386. doi:10.2337/dc10-1354. PubMed: 21216848.
14. Demmer RT, Squillaro A, Papapanou PN, Rosenbaum M, Friedewald WT, et al. (2012) Periodontal Infection, Systemic Inflammation, and Insulin Resistance: Results from the Continuous National Health and Nutrition Examination Survey (NHANES) 1999-2004. Diabetes Care, 35: 2235-42. PubMed: 22837370.
15. Vergnes JN, Sixou M, (2007) Preterm low birth weight and maternal periodontal status: a meta-analysis. Am J Obstet Gynecol 196135:: e1-e7. PubMed: 17306654.
16. Conde-Agudelo A, Villar J, Lindheimer M, (2008) Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 198: 7-22. doi:10.1016/j.ajog.2007.07.040. PubMed: 18166297.
17. Al-Katma MK, Bissada NF, Bordeaux JM, Sue J, Askari AD, (2007) Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol 13: 134-137. doi:10.1097/RHU.0b013e3180690616. PubMed: 17551378.
18. de Pablo P, Dietrich T, McAlindon TE, (2008) Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 35: 70-76. PubMed: 18050377.
19. Ortiz P, Bissada NF, Palomo L, Han YW, Al-Zahrani MS, et al. (2009) Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 80: 535-540. doi:10.1902/jop.2009.080447. PubMed: 19335072.
20. Demmer RT, Molitor JA, Jacobs DR Jr., Michalowicz BS, (2011) Periodontal Disease, Tooth Loss and Incident Rheumatoid Arthritis: Results from the First National Health and Nutrition Examination Survey and its epidemiological follow-up study. J Clin Periodontol 38: 998-1006. doi:10.1111/j.1600-051X.2011.01776.x. PubMed: 22092471.
21. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH, (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. [see comments]. [erratum appears in N Engl J Med 1997 Jul 31;337(5):356]. N Engl J Med 336: 973-979. doi:10.1056/NEJM199704033361401. PubMed: 9077376.
22. Ridker PM, Hennekens CH, Buring JE, Rifai N, (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843. doi:10.1056/NEJM200003233421202. PubMed: 10733371.
23. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM, (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327-334. doi:10.1001/jama.286.3.327. PubMed: 11466099.
24. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE, (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53: 693-700. doi:10.2337/diabetes.53.3.693. PubMed: 14988254.
25. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, et al. (2012) Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation 125: 2520-2544. doi:10.1161/CIR.0b013e31825719f3. PubMed: 22514251.
26. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, et al. (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511. doi:10.1161/01.CIR.0000052939.59093.45. PubMed: 12551878.
27. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151: 264-269, W64 doi:10.7326/0003-4819-151-4-200908180-00135. PubMed: 19622511.
28. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, et al. (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343: d5928. doi:10.1136/bmj.d5928. PubMed: 22008217.
29. Michalowicz BS, Novak MJ, Hodges JS, DiAngelis A, Buchanan W, et al. (2009) Serum inflammatory mediators in pregnancy: changes after periodontal treatment and association with pregnancy outcomes. J Periodontol 80: 1731-1741. doi:10.1902/jop.2009.090236. PubMed: 19905943.
30. Higgins JP, White IR, Anzures-Cabrera J, (2008) Meta-analysis of skewed data: combining results reported on log-transformed or raw scales. Statist Med 27: 6072-6092. doi:10.1002/sim.3427.
31. Higgins JGS, (2011) Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 The Cochrane Collaboration, 2011.
32. D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS, (2005) Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 84: 269-273. doi:10.1177/154405910508400312. PubMed: 15723869.
33. D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, et al. (2006) Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J 151: 977-984. doi:10.1016/j.ahj.2005.06.018. PubMed: 16644317.
34. Ide M, McPartlin D, Coward PY, Crook M, Lumb P, et al. (2003) Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontol 30: 334-340. doi:10.1034/j.1600-051X.2003.00282.x. PubMed: 12694432.
35. Offenbacher S, Lin D, Strauss R, McKaig R, Irving J, et al. (2006) Effects of periodontal therapy during pregnancy on periodontal status, biologic parameters, and pregnancy outcomes: a pilot study. J Periodontol 77: 2011-2024. doi:10.1902/jop.2006.060047. PubMed: 17209786.
36. Katagiri S, Nitta H, Nagasawa T, Uchimura I, Izumiyama H, et al. (2009) Multi-center intervention study on glycohemoglobin (HbA1c) and serum, high-sensitivity CRP (hs-CRP) after local anti-infectious periodontal treatment in type 2 diabetic patients with periodontal disease. Diabetes Res Clin Practice 83: 308-315. doi:10.1016/j.diabres.2008.10.016. PubMed: 19168253.
37. Offenbacher S, Beck JD, Moss K, Mendoza L, Paquette DW, et al. (2009) Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol 80: 190-201. doi:10.1902/jop.2009.080007. PubMed: 19186958.
38. Pinho Mde N, Oliveira RD, Novaes AB Jr., Voltarelli JC, (2009) Relationship between periodontitis and rheumatoid arthritis and the effect of non-surgical periodontal treatment. Braz Dent J 20: 355-364. PubMed: 20126902.
39. Vidal F, Figueredo CM, Cordovil I, Fischer RG, (2009) Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol 80: 786-791. doi:10.1902/jop.2009.080471. PubMed: 19405832.
40. Sun WL, Chen LL, Zhang SZ, Ren YZ, Qin GM, (2010) Changes of adiponectin and inflammatory cytokines after periodontal intervention in type 2 diabetes patients with periodontitis. Arch Oral Biol 55: 970-974. doi:10.1016/j.archoralbio.2010.08.001. PubMed: 20889139.
41. Taylor B, Tofler G, Morel-Kopp MC, Carey H, Carter T, et al. (2010) The effect of initial treatment of periodontitis on systemic markers of inflammation and cardiovascular risk: a randomized controlled trial. Eur J Oral Sci 118: 350-356. doi:10.1111/j.1600-0722.2010.00748.x. PubMed: 20662907.
42. Gonzales JR, Harnack L, Schmitt-Corsitto G, Boedeker RH, Chakraborty T, et al. (2011) A novel approach to the use of subgingival controlled-release chlorhexidine delivery in chronic periodontitis: a randomized clinical trial. J Periodontol 82: 1131-1139. doi:10.1902/jop.2011.100287. PubMed: 21491990.
43. Joseph R, Narayan V, Krishnan R, Melemadathil S, (2011) Non-surgical periodontal therapy improves serum levels of C-reactive protein and edematous states in female patients with idiopathic edema. J Periodontol 82: 201-209. doi:10.1902/jop.2010.100258. PubMed: 20681817.
44. Kamil W, Al Habashneh R, Khader Y, Al Bayati L, Taani D, (2011) Effects of nonsurgical periodontal therapy on C-reactive protein and serum lipids in Jordanian adults with advanced periodontitis. J Periodontal Res 46: 616-621. PubMed: 21631509.
45. Li X, Tse HF, Yiu KH, Li LS, Jin L, (2011) Effect of periodontal treatment on circulating CD34(+) cells and peripheral vascular endothelial function: a randomized controlled trial. J Clin Periodontol 38: 148-156. doi:10.1111/j.1600-051X.2010.01651.x. PubMed: 21133981.
46. Sun WL, Chen LL, Zhang SZ, Wu YM, Ren YZ, et al. (2011) Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis. Intern Med 50: 1569-1574. doi:10.2169/internalmedicine.50.5166. PubMed: 21804283.
47. Bokhari SA, Khan AA, Butt AK, Azhar M, Hanif M, et al. (2012) Non-surgical periodontal therapy reduces coronary heart disease risk markers: a randomized controlled trial. J Clin Periodontol 39: 1065-1074. doi:10.1111/j.1600-051X.2012.01942.x. PubMed: 22966824.
48. Chen L, Luo G, Xuan D, Wei B, Liu F, et al. (2012) Effects of non-surgical periodontal treatment on clinical response, serum inflammatory parameters, and metabolic control in patients with type 2 diabetes: a randomized study. J Periodontol 83: 435-443. doi:10.1902/jop.2011.110327. PubMed: 21859323.
49. Koromantzos PA, Makrilakis K, Dereka X, Offenbacher S, Katsilambros N, et al. (2012) Effect of non-surgical periodontal therapy on C-reactive protein, oxidative stress, and matrix metalloproteinase (MMP)-9 and MMP-2 levels in patients with type 2 diabetes: a randomized controlled study. J Periodontol 83: 3-10. doi:10.1902/jop.2011.110148. PubMed: 21627458.
50. Lin SJ, Tu YK, Tsai SC, Lai SM, Lu HK, (2012) Non-surgical periodontal therapy with and without subgingival minocycline administration in patients with poorly controlled type II diabetes: a randomized controlled clinical trial. Clin Oral Investig 16: 599-609. doi:10.1007/s00784-011-0535-x. PubMed: 21416238.
51. Llambés F, Silvestre FJ, Hernández-Mijares A, Guiha R, Bautista D, et al. (2012) Efect of periodontal disease and non surgical periodontal treatment on C-reactive protein. Evaluation of type 1 diabetic patients. Med Oral Patol Oral Cir Bucal 17: e562-e568. PubMed: 22322513.
52. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, et al. (2007) Treatment of periodontitis and endothelial function. N Engl J Med 356: 911-920. doi:10.1056/NEJMoa063186. PubMed: 17329698.
53. Tüter G, Kurtiş B, Serdar M, Aykan T, Okyay K, et al. (2007) Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease. J Clin Periodontol 34: 673-681. doi:10.1111/j.1600-051X.2007.01104.x. PubMed: 17590156.
54. Tüter G, Serdar M, Kurtiş B, Walker SG, Atak A, et al. (2010) Effects of scaling and root planing and subantimicrobial dose doxycycline on gingival crevicular fluid levels of matrix metalloproteinase-8,-13 and serum levels of HsCRP in patients with chronic periodontitis. J Periodontol 81: 1132-1139. doi:10.1902/jop.2010.090694. PubMed: 20370419.
55. López NJ, Quintero A, Casanova PA, Ibieta CI, Baelum V, et al. (2012) Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a controlled clinical trial. J Periodontol 83: 267-278. doi:10.1902/jop.2011.110227. PubMed: 21749167.
56. D'Aiuto F, Parkar M, Tonetti MS, (2005) Periodontal therapy: a novel acute inflammatory model. Inflamm Res 54: 412-414. doi:10.1007/s00011-005-1375-4. PubMed: 16283108.
57. Kebschull M, Demmer RT, Papapanou PN, (2010) "Gum bug, leave my heart alone!"--epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J Dent Res 89: 879-902. doi:10.1177/0022034510375281. PubMed: 20639510.
58. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr., et al. (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195-2207. doi:10.1056/NEJMoa0807646. PubMed: 18997196.
59. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, et al. (2005) C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352: 20-28. doi:10.1056/NEJMoa042378. PubMed: 15635109.
60. Wang X, Bao W, Liu J, Ouyang YY, Wang D, et al. (2013) Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 36: 166-175. doi:10.2337/dc12-0702. PubMed: 23264288.
61. Janket SJ, Wightman A, Baird AE, Van Dyke TE, Jones JA, (2005) Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res 84: 1154-1159. doi:10.1177/154405910508401212. PubMed: 16304446.
62. Michalowicz BS, Hodges JS, DiAngelis AJ, Lupo VR, Novak MJ, et al. (2006) Treatment of periodontal disease and the risk of preterm birth. N Engl J Med 355: 1885-1894. doi:10.1056/NEJMoa062249. PubMed: 17079762.
63. Beck JD, Couper DJ, Falkner KL, Graham SP, Grossi SG, et al. (2008) The Periodontitis and Vascular Events (PAVE) pilot study: adverse events. J Periodontol 79: 90-96. doi:10.1902/jop.2008.070223. PubMed: 18166097.
64. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, et al. (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375: 735-742. doi:10.1016/S0140-6736(09)61965-6. PubMed: 20167359.
65. Ioannidou E, Malekzadeh T, Dongari-Bagtzoglou A, (2006) Effect of periodontal treatment on serum C-reactive protein levels: a systematic review and meta-analysis. J Periodontol 77: 1635-1642. doi:10.1902/jop.2006.050443. PubMed: 17032104.
66. Paraskevas S, Huizinga JD, Loos BG, (2008) A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 35: 277-290. doi:10.1111/j.1600-051X.2007.01173.x. PubMed: 18294231.
67. Ide M, Jagdev D, Coward PY, Crook M, Barclay GR, et al. (2004) The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. J Periodontol 75: 420-428. doi:10.1902/jop.2004.75.3.420. PubMed: 15088881.
68. Seinost G, Wimmer G, Skerget M, Thaller E, Brodmann M, et al. (2005) Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J 149: 1050-1054. doi:10.1016/j.ahj.2004.09.059. PubMed: 15976787.